Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
N-Phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide REF: IN-DA003TB2CAS: 681136-29-8 | 98% | To inquire | Tue 07 Jan 25 | |
JNJ-1661010 REF: TM-T2684CAS: 681136-29-8 | 99.79% - 99.97% | 34.00 €~225.00 € | Mon 13 Jan 25 | |
N-Phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide REF: 10-F521420CAS: 681136-29-8 | 95.0% | To inquire | Tue 14 Jan 25 | |
JNJ-1661010 REF: 3D-GCB13629CAS: 681136-29-8 | Min. 95% | - - - | Discontinued product |
N-Phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide
CAS:681136-29-8
Formula:
C19H19N5OS
Purity:
98%
Color and Shape:
Solid
Molecular weight:
365.4521
Ref: IN-DA003TB2
1g | To inquire | ||
10mg | 147.00 € | ||
50mg | 176.00 € | ||
100mg | 280.00 € | ||
250mg | 629.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
JNJ-1661010
CAS:681136-29-8
JNJ-1661010 (Takeda-25) is an effective and specific FAAH inhibitor (IC50: 10/ 12 nM for rat/human), …
Formula:
C19H19N5OS
Purity:
99.79% - 99.97%
Color and Shape:
Solid
Molecular weight:
365.45
- Amides
- Inhibitors
- Metabolism
- FAAH
- See more categories
- Analgesic
Ref: TM-T2684
10mg | 45.00 € | ||
25mg | 91.00 € | ||
50mg | 130.00 € | ||
100mg | 225.00 € | ||
1mL*10mM (DMSO) | 34.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
N-Phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide
CAS:681136-29-8
Purity:
95.0%
Molecular weight:
365.4599914550781
Ref: 10-F521420
250mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
JNJ-1661010
CAS:681136-29-8
JNJ-1661010 is a non-selective, orally active, potent and selective small molecule antagonist of the neurokinin-1 …
Formula:
C19H19N5OS
Purity:
Min. 95%
Molecular weight:
365.45 g/mol
Ref: 3D-GCB13629
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |